Videos Archives

November 7, 2025

On October 21, 2025, results from Alector Therapeutics’ Phase 3 clinical trial for Latozinemab (AL001) were announced….

Read More >

October 21, 2025

When a family learns FTD is genetic, it’s important to find relatives and convey the potential risk…

Read More >

October 13, 2025

While awareness of FTD disorders is increasing, many people still face a lengthy and complicated…

Read More >

June 20, 2023

AFTD held its 2023 Education Conference on May 5, both in person in St. Louis and virtually….

Read More >

May 5, 2022

AFTD CEO Susan L-J Dickinson, MSGC, talked about FTD and its connection to ALS during an interview…

Read More >

October 2, 2021

To mark World FTD Awareness Week 2021, AFTD has worked with the international coalition World FTD United…

Read More >

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

What's New